Article

Study Raises Concerns About Accuracy of Insulin Dosing Apps

The study, conducted by the Global eHealth Unit at the Imperial College London, has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin. Does this demand an FDA oversight of the apps?

A recent study led by the Global eHealth Unit at the Imperial College London has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin.

For patients on insulin, meal-time dosing of short-acting insulin is a challenging task. There are a lot of factors that go in to deciding how much insulin to administer—anticipated carbohydrate intake, premeal blood sugar, planned activities afterwards, and more. A simple calculator app to help out seems like a no-brainer. And there are a lot of apps out there that claim to do that.

Huckvale and colleagues found 46 insulin dose calculator apps in the app stores. When they evaluated these apps, they found some pretty concerning patterns.

Read the complete article on MedpageToday: http://bit.ly/1PIpbOI

Related Videos
Masanori Aikawa, MD
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo